<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04807322</url>
  </required_header>
  <id_info>
    <org_study_id>RTSA in very old patients</org_study_id>
    <nct_id>NCT04807322</nct_id>
  </id_info>
  <brief_title>Reverse Total Shoulder Arthroplasty in Patients Who Exceeded Their Life-expectancy: a Retrospective Study</brief_title>
  <official_title>Reverse Total Shoulder Arthroplasty in Patients Who Exceeded Their Life-expectancy: a Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bürgerspital Solothurn</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bürgerspital Solothurn</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Reverse total shoulder arthroplasty (RTSA) has become an established treatment for cuff&#xD;
      arthropathy, severe osteoarthritis and in certain fracture cases. Due to the increasingly&#xD;
      aging population, patients who have already exceeded their life-expectancy pose a significant&#xD;
      challenge to the shoulder surgeon. Therefore, we wanted to investigate patient demographics,&#xD;
      hospital stay length, complication rate functional outcome, patient reported outcome scores&#xD;
      and mortality retrospectively for patients, who were older than 83 years at time of&#xD;
      implantation of a RTSA.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective single institution study. All patients older than 83 years who&#xD;
      received a reverse shoulder arthroplasty from 2008 until 2019 are included. Elective cases&#xD;
      are compared to fracture cases (patient demographics, length of hospital stay, complication&#xD;
      rate, functional outcome, patient reported outcome scores and mortality).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 24, 2019</start_date>
  <completion_date type="Actual">December 21, 2020</completion_date>
  <primary_completion_date type="Actual">August 4, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patient reported outcome score: ASES</measure>
    <time_frame>until august 2020</time_frame>
    <description>American Shoulder and Elbow Society (ASES) Score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication rate</measure>
    <time_frame>until august 2020</time_frame>
    <description>postoperative complications requiring surgical intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality adjusted life year (QALY)</measure>
    <time_frame>until august 2020</time_frame>
    <description>The quality adjusted life year (QALY) ) is a well-established indicator of the life quality for the remaining years and was calculated as the years of life following the operation, multiplied by the utility value, for the current study, defined as the postoperative American Shoulder and Elbow Surgeons Shoulder Score (ASES) score (0-1 points) at last follow-up.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>until august 2020</time_frame>
    <description>Survivership</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient reported outcome score: QuickDASH</measure>
    <time_frame>until august 2020</time_frame>
    <description>Quick Disabilities of the arm, shoulder and hand (DASH) Score,</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient reported outcome score: VAS</measure>
    <time_frame>until august 2020</time_frame>
    <description>Visual analog score (VAS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient demographics</measure>
    <time_frame>at time of surgery</time_frame>
    <description>male/female ratio, age, BMI, ASA (American Society of Anesthesiologists) classification, hospital stay length, range of motion</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">110</enrollment>
  <condition>Reverse Total Shoulder Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Elective cases</arm_group_label>
    <description>Patients, who received a RTSA for degenerative reasons like cuff arthropathy or osteoarthritis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fracture cases</arm_group_label>
    <description>Patients, who received a RTSA for a proximal humerus fracture</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Reverse Total Shoulder Arthroplasty (RTSA)</intervention_name>
    <description>Implantation of a Reverse Total Shoulder Arthroplasty</description>
    <arm_group_label>Elective cases</arm_group_label>
    <arm_group_label>Fracture cases</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have already exceeded their life-expectancy (83 years in Switzerland)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients older than 83 years at time of surgery&#xD;
&#xD;
          -  Patients who received a reverse total shoulder arthroplasty&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients younger than 83 years at time of surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>83 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mai Lan Dao Trong, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bürgerspital Solothurn</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bürgerspital Solothurn</name>
      <address>
        <city>Solothurn</city>
        <zip>4500</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 16, 2021</study_first_submitted>
  <study_first_submitted_qc>March 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2021</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bürgerspital Solothurn</investigator_affiliation>
    <investigator_full_name>Mai Lan Dao Trong</investigator_full_name>
    <investigator_title>Attending physician shoulder and elbow surgery</investigator_title>
  </responsible_party>
  <keyword>reverse total shoulder arthroplasty</keyword>
  <keyword>RTSA</keyword>
  <keyword>elderly</keyword>
  <keyword>proximal humerus fracture</keyword>
  <keyword>cuff arthropathy</keyword>
  <keyword>outcome</keyword>
  <keyword>complications</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>June 13, 2021</submitted>
    <returned>July 2, 2021</returned>
    <submitted>August 30, 2021</submitted>
    <returned>September 23, 2021</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

